Sequoia Logo

BridgeBio develops breakthrough medicines for genetic diseases. Its portfolio of more than 15 drugs, all in various stages of development, addresses everything from genetic skin, cancer- and heart-related issues to renal disease.

Healthcare
  • Founded 2014
  • Partnered 2018
  • IPO 2019